Patents by Inventor Yoshifusa KONDO

Yoshifusa KONDO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11963978
    Abstract: Provided is a method or the like for producing a composition exhibiting cytocidal activity. This method for producing a composition exhibiting cytocidal activity comprises: culturing malignant tumor-derived cells in a culture medium at least until the cell density reaches a level that does not pose a problem for transfer; replacing, after culturing, the culture medium with a physiological buffer salt solution; and recovering the physiological buffer salt solution after death of the malignant tumor-derived cells is observed morphologically in the physiological buffer salt solution.
    Type: Grant
    Filed: September 9, 2021
    Date of Patent: April 23, 2024
    Assignee: Medical Corporation Ichikawa Clinic
    Inventors: Tomoyuki Tajima, Yoshifusa Kondo
  • Patent number: 11318162
    Abstract: Provided is a method or the like for producing a composition exhibiting cytocidal activity. This method for producing a composition exhibiting cytocidal activity comprises: culturing malignant tumor-derived cells in a culture medium at least until the cell density reaches a level that does not pose a problem for transfer; replacing, after culturing, the culture medium with a physiological buffer salt solution; and recovering the physiological buffer salt solution after death of the malignant tumor-derived cells is observed morphologically in the physiological buffer salt solution.
    Type: Grant
    Filed: October 5, 2018
    Date of Patent: May 3, 2022
    Assignee: Medical Corporation Ichikawa Clinic
    Inventors: Tomoyuki Tajima, Yoshifusa Kondo
  • Publication number: 20210401882
    Abstract: Provided is a method or the like for producing a composition exhibiting cytocidal activity. This method for producing a composition exhibiting cytocidal activity comprises: culturing malignant tumor-derived cells in a culture medium at least until the cell density reaches a level that does not pose a problem for transfer; replacing, after culturing, the culture medium with a physiological buffer salt solution; and recovering the physiological buffer salt solution after death of the malignant tumor-derived cells is observed morphologically in the physiological buffer salt solution.
    Type: Application
    Filed: September 9, 2021
    Publication date: December 30, 2021
    Applicant: Medical Corporation Ichikawa Clinic
    Inventors: Tomoyuki TAJIMA, Yoshifusa KONDO
  • Publication number: 20200222458
    Abstract: Provided is a method or the like for producing a composition exhibiting cytocidal activity. This method for producing a composition exhibiting cytocidal activity comprises: culturing malignant tumor-derived cells in a culture medium at least until the cell density reaches a level that does not pose a problem for transfer; replacing, after culturing, the culture medium with a physiological buffer salt solution; and recovering the physiological buffer salt solution after death of the malignant tumor-derived cells is observed morphologically in the physiological buffer salt solution.
    Type: Application
    Filed: October 5, 2018
    Publication date: July 16, 2020
    Applicant: Medical Corporation Ichikawa Clinic
    Inventors: Tomoyuki TAJIMA, Yoshifusa KONDO